<p>Brain or spinal cord tissue was homogenized and analysed by Western blot as described in <i>Material & Methods</i> with various anti-PrP antibodies. Hooded Seal, one sample lanes 1–6; domestic dog, one sample lanes 7–8; domestic cat, two samples, 9–10 and 11–13; Brown bear, three samples 14–15, 16–17, 18–19. Untreated PrP<sup>C</sup>: lanes 1,3,5,7,9,11,14,16,18. Deglycosylated PrP<sup>C</sup> (+): lanes 2,4,6,8,10,12,13,15,17,19. Detection using antibodies with epitopes N-terminal to α-cleavage site: SAF32 (lanes 1–2) or F11 (lane 12), with epitope in α-cleavage site: 3F4 (lanes 3–4), with epitopes C-terminal to α-cleavage site: Bar224 (lanes 5–10, 14–19), 6H4 (lane 11) or BC6 (lane 13).</p
<p>A) Western Blot analysis for PrP<sup>Sc</sup> (frontal cortex) of vCJD, BSE and sCJD infected ani...
<p>Homogenates were subjected to proteinase K digestion followed by immunoblotting using Sha31 monoc...
(A) Representative western blot showing shed PrP (detected with our new antibody described in [36]) ...
Each lane represents PK-digested PrPSc probed with an anti-PrP monoclonal antibody P4. Lane key: MW,...
<p>(<b>A</b>) Samples from five brain regions of calf #83 demonstrate the characteristic 3-band prof...
Western blot (A) and migration analysis (B, C) of PrPSc from 139H, DY or ME7H-infected PK digested b...
<p>(A) Western blotting of Op, MoPrP<sup>+/+</sup> and MoPrP<sup>−/−</sup> whole brain homogenates c...
<p>Immunoblots of brain PrP<sup>res</sup> detected with SHA 31 and 12B2 mAbs. Similar quantities of ...
(A) Western blot analysis. Homogenates of bovine and monkey brains were digested by PK, and subjecte...
<p>The antibody used to detect PrP<sup>sc</sup> was mAb Sha31 as provided by the protocol test. Rela...
Detection of PrPSc is shown in the 10−1 dilution of unamplified CWD+ cervid brain homogenate CBP6 (5...
<p>2D Western blotting of brain homogenates from <i>Neu3</i><sup><i>-/-</i></sup> (a), <i>Neu3</i><s...
<p>Each lane represents PK-digested PrP<sup>Sc</sup> probed with an anti-PrP monoclonal antibody. Mo...
<p>2D Western blotting of brain homogenates from FVB <i>Neu1</i><sup><i>-/-</i></sup> (a) and corres...
<p>(<b>A</b>) Brain homogenates from terminally ill wt and PrP(TetraH>G) line 34 mice were either le...
<p>A) Western Blot analysis for PrP<sup>Sc</sup> (frontal cortex) of vCJD, BSE and sCJD infected ani...
<p>Homogenates were subjected to proteinase K digestion followed by immunoblotting using Sha31 monoc...
(A) Representative western blot showing shed PrP (detected with our new antibody described in [36]) ...
Each lane represents PK-digested PrPSc probed with an anti-PrP monoclonal antibody P4. Lane key: MW,...
<p>(<b>A</b>) Samples from five brain regions of calf #83 demonstrate the characteristic 3-band prof...
Western blot (A) and migration analysis (B, C) of PrPSc from 139H, DY or ME7H-infected PK digested b...
<p>(A) Western blotting of Op, MoPrP<sup>+/+</sup> and MoPrP<sup>−/−</sup> whole brain homogenates c...
<p>Immunoblots of brain PrP<sup>res</sup> detected with SHA 31 and 12B2 mAbs. Similar quantities of ...
(A) Western blot analysis. Homogenates of bovine and monkey brains were digested by PK, and subjecte...
<p>The antibody used to detect PrP<sup>sc</sup> was mAb Sha31 as provided by the protocol test. Rela...
Detection of PrPSc is shown in the 10−1 dilution of unamplified CWD+ cervid brain homogenate CBP6 (5...
<p>2D Western blotting of brain homogenates from <i>Neu3</i><sup><i>-/-</i></sup> (a), <i>Neu3</i><s...
<p>Each lane represents PK-digested PrP<sup>Sc</sup> probed with an anti-PrP monoclonal antibody. Mo...
<p>2D Western blotting of brain homogenates from FVB <i>Neu1</i><sup><i>-/-</i></sup> (a) and corres...
<p>(<b>A</b>) Brain homogenates from terminally ill wt and PrP(TetraH>G) line 34 mice were either le...
<p>A) Western Blot analysis for PrP<sup>Sc</sup> (frontal cortex) of vCJD, BSE and sCJD infected ani...
<p>Homogenates were subjected to proteinase K digestion followed by immunoblotting using Sha31 monoc...
(A) Representative western blot showing shed PrP (detected with our new antibody described in [36]) ...